Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Metformin (Glumetza, Riomet) and semaglutide (Wegovy) are both medications that can manage metabolic conditions like diabetes or obesity. Metformin is a biguanide that treats Type 2 diabetes, helping control blood sugar by reducing the amount of sugar your body makes and improving insulin use in the body. It is taken orally, usually once or twice a day, and is available in both short-acting and long-acting forms. Common side effects include stomach issues like diarrhea and nausea. Semaglutide, on the other hand, is a glucagon-like peptide-1 (GLP-1) receptor agonist that is injected under the skin once a week. As Wegovy, it is primarily used for long-term weight management and to lower the risk of heart problems in certain adults. Other forms of semaglutide like Ozempic and Rybelsus are used for treating Type 2 diabetes. Common side effects include nausea, diarrhea, and stomach pain. Unlike metformin, semaglutide injection requires refrigeration and has a potential risk for thyroid cancer. Both medications can interact with other diabetes medications, potentially causing low blood sugar.
Metformin
Wegovy (semaglutide)
Metformin
Wegovy (semaglutide)
Summary of Metformin vs. Wegovy
Summary for Biguanide
Prescription only
Immediate-release metformin is an oral diabetes medication. It's approved for people 10 years of age and older with Type 2 diabetes. The medication belongs to the drug class called biguanides. It works best to lower blood sugar levels with a diabetes-friendly diet and exercise plan. Immediate-release metformin comes as a tablet and an oral solution. You take this medication by mouth usually two to three times a day. It's recommended to take each dosage with food to help lessen side effects like diarrhea and nausea.
Summary for GLP-1 agonist
Prescription only
Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist. It comes in prefilled pens you use to inject the medication under the skin once a week. Wegovy (semaglutide) also comes as tablets that are swallowed once a day. This medication is approved for weight loss in some people. It can help lower the risk of heart attack, stroke, and death due to heart problems in adults with a larger body size and heart disease. The pens are also approved for certain adults with a liver problem called metabolic dysfunction-associated steatohepatitis (MASH). The medication works best when taken with a lower-calorie diet and regular exercise. Side effects include nausea, diarrhea, and stomach pain.